中国中药(00570) - 股东权益变动
最后更新于:2025-04-08
*注解:(L)- 好仓, (S)- 淡仓, (P)- 可供借出的股份。
全部购买出售
全部董事非董事
| # | 日期 | 股东名称 | 披露原因 | 改变数量 | 成交均价 | 金额 | 持有权益的股份数量 | 占已发行的有投票权股份百分比 | 表格序号 |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025-04-08 | 中國醫藥集團有限公司 | 1.86港币 | CS20250410E00206 | |||||
| 2 | 2024-10-22 | Schulte-Hillen Friedrich Bela | 2.53港币 | IS20241024E00056 | |||||
| 3 | 2024-10-22 | Moskey Matthew Love | 2.53港币 | IS20241024E00054 | |||||
| 4 | 2024-10-22 | Athos Capital Limited | 2.53港币 | CS20241024E00051 | |||||
| 5 | 2024-10-21 | Schulte-Hillen Friedrich Bela | 2.38港币 | IS20241024E00026 | |||||
| 6 | 2024-10-21 | Moskey Matthew Love | 2.38港币 | IS20241024E00025 | |||||
| 7 | 2024-10-21 | Athos Capital Limited | 2.38港币 | CS20241024E00024 | |||||
| 8 | 2024-10-16 | JPMorgan Chase & Co. | 4.33港币 | CS20241021E00447 | |||||
| 9 | 2024-09-24 | Rohr George | 4.32港币 | IS20240927E00484 | |||||
| 10 | 2024-09-24 | Millennium Partners, L.P. | 4.32港币 | CS20240927E00476 | |||||
| 11 | 2024-09-24 | Millennium Offshore Intermediate, L.P. | 4.32港币 | CS20240927E00480 | |||||
| 12 | 2024-09-24 | Millennium Management LLC | 4.32港币 | CS20240927E00477 | |||||
| 13 | 2024-09-24 | Millennium International, Ltd. | 4.32港币 | CS20240927E00481 | |||||
| 14 | 2024-09-24 | Millennium Group Management LLC | 4.32港币 | CS20240927E00478 | |||||
| 15 | 2024-09-24 | MLM Trust B LLC | 4.32港币 | CS20240927E00482 | |||||
| 16 | 2024-09-24 | Integrated Holding Group LP | 4.32港币 | CS20240927E00475 | |||||
| 17 | 2024-09-24 | Integrated Core Strategies (Asia) Pte. Ltd. | 4.32港币 | CS20240927E00474 | |||||
| 18 | 2024-09-24 | Englander Israel Alexander | 4.32港币 | IS20240927E00483 | |||||
| 19 | 2024-08-16 | The Goldman Sachs Group, Inc. | 4.10港币 | CS20240821E00186 | |||||
| 20 | 2024-05-20 | UBS Group AG | 4.28港币 | CS20240523E00346 | |||||
| 21 | 2024-05-08 | UBS Group AG | 4.31港币 | CS20240513E00277 |